FDA 483 - Homayoon (nmi) Khanlou, M.D. - August 18, 2017

Honyoon (nmi) Khanlou, M.D. in Beverly Hills, CA, was inspected and cited for significant protocol deviations during clinical investigations. The inspection revealed failures to conduct required physical exams, ECGs, and questionnaires, as well as issues with maintaining accurate case histories. These findings indicate a lack of adherence to the investigational plan and proper documentation practices.